Platelet-rich plasma injection for acute Achilles tendon rupture : two-year follow-up of the PATH-2 randomized, placebo-controlled, superiority trial.

David J Keene,Joseph Alsousou,Paul Harrison, Heather M O'Connor,Susan Wagland,Susan J Dutton,Philippa Hulley,Sarah E Lamb,Keith Willett

The bone & joint journal（2022）

引用 1|浏览5

暂无评分

摘要

PRP injection did not improve patient-reported function or quality of life two years after acute Achilles tendon rupture compared with placebo. The evidence from this study indicates that PRP offers no patient benefit in the longer term for patients with acute Achilles tendon rupture.Cite this article: 2022;104-B(11):1256-1265.

查看译文

关键词

ATRS scores,Achilles Tendon Rupture Score (ATRS),Achilles tendon,Platelet-rich plasma,Randomized controlled trial,Tendon rupture,acute Achilles tendon rupture,anticoagulation therapy,leg injury,placebo injection,platelet-rich plasma (PRP),platelet-rich plasma (PRP) injection,platelets,re-ruptures

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要